Pipeline preview.
- Published in:
- Formulary, 2012, v. 47, n. 10, p. 348
- Publication type:
- Article
Works matching IS 1082801X AND DT 2012 AND VI 47 AND IP 10
Results: 8
1
2
FDA actions in brief.
- Published in:
- Formulary, 2012, v. 47, n. 10, p. 349
- Publication type:
- Article
3
New molecular entity.
- Published in:
- Formulary, 2012, v. 47, n. 10, p. 348
- Publication type:
- Article
4
Focus on... Tofacitinib: A novel oral Janus kinase inhibitor for rheumatoid arthritis.
- Published in:
- Formulary, 2012, v. 47, n. 10, p. 350
- By:
- Publication type:
- Article
5
Take charge of medication reconciliation to reduce readmission rates.
- Published in:
- Formulary, 2012, v. 47, n. 10, p. 343
- By:
- Publication type:
- Article
6
Meeting Coverage. Modifying antiplatelet therapy based on platelet function testing does not improve outcomes in stroke/TIA patients.
- Published in:
- 2012
- Publication type:
- Proceeding
7
Incretin-based therapies: A focus on safety concerns and emerging uses.
- Published in:
- Formulary, 2012, v. 47, n. 10, p. 369
- By:
- Publication type:
- Article
8
Current standards and future treatments of rheumatoid arthritis.
- Published in:
- Formulary, 2012, v. 47, n. 10, p. 359
- By:
- Publication type:
- Article